Br J Cancer: Regulatory T cells can predict the clinical outcome of patients with soft tissue sarcoma
Time of Update: 2021-06-21
The prognostic impact of this study is to analyze tumor infiltrating lymphocytes (TIL) and immune checkpoint markers in STS, and to evaluate its local recurrence (LR), distant metastasis (DM) and overall survival (OS) of the disease.
New cell therapy! The FDA grants the same allogeneic active degeneration degeneration cell
Time of Update: 2021-01-29
28, 2021 /// -- Immunicum AB, a Swedish biotechnology company dedicated to the development of isomer, idiopathic cell therapies, has developed a unique immuno-oncology approach to improve patient survival and quality of life by launching
Nat Commun: Single-cell analysis reveals different immune conditions for transplanted tumors
Time of Update: 2020-12-31
, however, most preclinical immunotherapy studies focused on transplant tumor models, showing higher cure rates after combined immuno-checkpoint blocking and RT.
NEJM: Metastatic transparent cell sarcoma - case reports.
Time of Update: 2020-07-30
the patient underwent an ultrasound-led biopsy of abdominal lesions, and histopathological analysis revealed a transparent cell sarcoma (shown in Figure B).
A case of celiac synaptic cell sarcoma with paratumor natural blister anaesthetic
Time of Update: 2020-07-16
the patient was highly suspected before surgery that PNP was associated with post-peritoneal Castleman disease, while the tumor pathology of intraoperative excision combined with immunohiscitision was a preliminary diagnosis of FDCS.